Skip to content

ALXO

ALX ONCOLOGY HOLDINGS INC

NASDAQ · Healthcare · Biotechnology · US

$1.70
−2.30%
Ask drillr
0
Insider buys (3m)
3
Insider sells (3m)
-$8.3K
Net value (3m)
+4.9%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 18, 2026Wong Shelly · officer: SVP, FINANCE AND CAOSale573$1.93
Aug 18, 2026Lettmann Jason · director, officer: CHIEF EXECUTIVE OFFICERSale2,230$1.93
Jul 6, 2026Wong Shelly · officer: SVP, FINANCE AND CAOSale1,404$2.04
Apr 17, 2026Klencke Barbara · officer: Chief Medical OfficerA-Award100,000$1.68
Apr 17, 2026Knight Jeff E. · officer: Chief Dev & Operating OfficerA-Award800,000$1.68
Mar 23, 2026Lettmann Jason · director, officer: CHIEF EXECUTIVE OFFICERSale12,311$2.17
Mar 23, 2026Pinto Shelly · officer: SVP, FINANCE AND CAOSale903$2.17
Mar 5, 2026Klencke Barbara · officer: Chief Medical OfficerA-Award700,000$2.07
Feb 20, 2026Pinto Shelly · officer: SVP, FINANCE AND CAOSale565$2.27
Feb 19, 2026Lettmann Jason · director, officer: CHIEF EXECUTIVE OFFICERF-InKind2,201$2.27
Feb 4, 2026GOODMAN COREY S · director, 10 percent owner: Purchase3,184,713$1.57
Jan 28, 2026Pinto Shelly · officer: SVP, FINANCE AND CAOA-Award192,000$1.48
Jan 28, 2026Shantharam Harish · officer: Chief Financial OfficerA-Award303,000$1.48
Jan 28, 2026Lettmann Jason · director, officer: CHIEF EXECUTIVE OFFICERA-Award912,000$1.48
Jan 21, 2026Takimoto Chris H · directorA-Award40,400$1.32
Jan 21, 2026Sandler Alan B. · directorA-Award10,100$1.32
Jan 21, 2026Curran Daniel J. · directorA-Award16,833$1.32
Jan 21, 2026Garland J. Scott · directorA-Award40,400$1.32
Jan 21, 2026Hemrajani Rekha · directorA-Award40,400$1.32
Jan 21, 2026GOODMAN COREY S · director, 10 percent owner: A-Award40,400$1.32
Jan 7, 2026Pinto Shelly · officer: SVP, FINANCE AND CAOSale3,925$1.11
Oct 16, 2025Pinto Shelly · officer: SVP, FINANCE AND CAOA-Award140,000$1.70
Oct 16, 2025Shantharam Harish · officer: Chief Financial OfficerA-Award198,750$1.70
Oct 16, 2025Lettmann Jason · director, officer: CHIEF EXECUTIVE OFFICERA-Award597,500$1.70
Sep 19, 2025Klencke Barbara · directorA-Award300,000$1.05
Sep 18, 2025Lettmann Jason · director, officer: CHIEF EXECUTIVE OFFICERPurchase21,070$1.07
Sep 18, 2025Lettmann Jason · director, officer: CHIEF EXECUTIVE OFFICERPurchase71,163$1.08
Aug 20, 2025Shantharam Harish · officer: Chief Financial OfficerPurchase75,000$0.78
Aug 19, 2025Pinto Shelly · officer: SVP, FINANCE AND CAOSale611$0.64
Aug 19, 2025Lettmann Jason · director, officer: CHIEF EXECUTIVE OFFICERSale2,382$0.64
Institutional positioning

13F filings over the trailing two quarters

New 62Increased 46Reduced 26Sold out 12
FilerActionSharesFiled
RA CAPITAL MANAGEMENT, L.P.Unchanged13,011,849Aug 14, 2026
TCG CROSSOVER MANAGEMENT, LLCNew Position13,011,849May 15, 2026
RA CAPITAL MANAGEMENT, L.P.New Position13,011,849May 15, 2026
VENBIO PARTNERS LLCIncreased12,884,638May 15, 2026
venBio Partners LLCUnchanged12,884,638Aug 14, 2026
REDMILE GROUP, LLCIncreased7,964,188May 15, 2026
BlackRock, Inc.Increased7,399,530Aug 7, 2026
Redmile Group, LLCReduced7,392,504Aug 14, 2026
Blackstone Inc.Increased6,593,543Aug 14, 2026
DRIEHAUS CAPITAL MANAGEMENT LLCIncreased6,025,240Aug 14, 2026
BLACKSTONE INC.New Position5,826,544May 15, 2026
SILVERARC CAPITAL MANAGEMENT, LLCNew Position5,744,757Aug 13, 2026
DRIEHAUS CAPITAL MANAGEMENT LLCIncreased5,734,620May 15, 2026
TCG Crossover Management, LLCReduced5,655,487Aug 14, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased4,973,436Aug 13, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 18, 2026